NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

內視鏡的全球市場(2020年):Frost Radar

Frost Radar: Global Endoscopy Market, 2020

出版商 Frost & Sullivan 商品編碼 985481
出版日期 內容資訊 英文 38 Pages
商品交期: 最快1-2個工作天內
價格
內視鏡的全球市場(2020年):Frost Radar Frost Radar: Global Endoscopy Market, 2020
出版日期: 2020年12月23日內容資訊: 英文 38 Pages
簡介

全球微創手術的需求有急速增加趨勢,因此導致這些手術所使用的創新的內視鏡設備的需求中長期性劇增。還有預計不得不清除COVID-19大流行所影響延期的 "選擇性手術" 的積壓。微創手術由於能大幅度縮短患者的住院時間,最小限度控制術後的併發症,受到患者和醫生的雙方喜愛。

為了提供創新的內視鏡技術,領導市場的企業,透過創新突破和獨特的市場擴展策略以差異化作為目標。膠囊投藥型,人工智慧裝載型,機器人支援型等,新類型的內視鏡引人注目。這些進步,由於設定照護投藥的新標準,提高患者的健康狀態,有效推動全球內視鏡設備市場。

本報告提供全球內視鏡市場的相關調查,各企業的優勢,機會,市場上的地位,競爭情形及策略,主要企業的簡介等資訊。

目錄

策略性命令及成長環境

  • 策略性命令
  • 成長環境

FrostRadar

  • FrostRadar:全球內視鏡市場
  • FrostRadar:競爭環境

活躍的企業

  • Olympus Corporation
  • Boston Scientific
  • Karl Storz-Endoskope
  • Medtronic plc.
  • Ambu A/S
  • Fujifilm Healthcare
  • Smith & Nephew, Inc.
  • Stryker Corporation
  • B. Braun
  • ConMed Corporation
  • PENTAX Medical
  • Auris Health
  • CapsoVision, Inc.

策略性洞察能力

  • 策略性洞察能力

下一步:FrostRadar的有效利用刺激主要利害關係者

  • 使用FrostRadar的重要性
  • FrostRadar刺激CEO的成長團隊
  • FrostRadar刺激投資者
  • FrostRadar刺激客戶
  • FrostRadar刺激董事會

FrostRadar分析

  • FrostRadar:未來的成長性的基準
  • 免責聲明
目錄
Product Code: MFDE-54

A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines

Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of "elective surgeries" that were postponed due to the COVID-19 pandemic. Specifically, the amount of surgeries involving the gastrointestinal (GI) tract, urology, and gynecology will flood healthcare systems once the world recovers from the pandemic, thus leading to increased use of endoscopy devices. Because minimally invasive surgeries substantially reduce a patient's time in hospital and minimize post-operative complications, this approach is preferred by both patients and doctors.

The US Food and Drug Administration (FDA) issued safety recommendations to use partially or fully-disposable duodenoscopes; that, in addition to the awareness COVID-19 created about infection prevention have boosted the development of single-use duodenoscopes and endoscopes. The FDA's recommendation is based on the fact that certain endoscope devices come with complicated designs and hard-to-clean components, which pose contamination risk from one patient to another if not correctly reprocessed and sterilized.

To supply innovative endoscopic technologies, leading market players aim to differentiate themselves with disruptive breakthroughs and distinctive market expansion strategies. Novel endoscope types are gaining increased attention, such as capsule administered, artificial intelligence (AI)-powered, and robotic-assisted. These advancements effectively propel the global endoscopy devices market by setting new standards of care delivery and enhanced patient health outcomes.

Frost & Sullivan's research indicates that the global endoscopy market, which is currently crowded by traditional rigid and reprocessed endoscopes, will soon experience a major shift toward flexible single-use devices. The technological innovations are expected to introduce major transformation to the market and create new standards of safety, efficiency, cost-effectiveness, and enhanced quality of care.

In a field of more than 70 global industry participants, Frost & Sullivan independently plotted the top 13 companies in this Frost Radar™ analysis. The Frost Radar™ reveals the market positioning of each company using its Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies based on their strengths, opportunities, and market positioning. We discuss strategic market imperatives and the competitive environment that vendors operate in as well as make recommendations for each provider to spur growth.

Table of Contents

Strategic Imperative and Growth Environment

  • Strategic Imperative
  • Strategic Imperative (continued)
  • Growth Environment
  • Growth Environment (continued)

Frost Radar™

  • Frost Radar™: Global Endoscopy Market
  • Frost Radar™: Competitive Environment
  • Frost Radar™: Competitive Environment (continued)

Companies to Action

  • Olympus Corporation
  • Boston Scientific
  • Karl Storz-Endoskope
  • Medtronic plc.
  • Ambu A/S
  • Fujifilm Healthcare
  • Smith & Nephew, Inc.
  • Stryker Corporation
  • B. Braun
  • ConMed Corporation
  • PENTAX Medical
  • Auris Health
  • CapsoVision, Inc.

Strategic Insights

  • Strategic Insights

Next Steps: Leveraging the Frost Radar™ to Empower Key Stakeholders

  • Significance of Being on the Frost Radar™
  • Frost Radar™ Empowers the CEO's Growth Team
  • Frost Radar™ Empowers Investors
  • Frost Radar™ Empowers Customers
  • Frost Radar™ Empowers the Board of Directors

Frost Radar™ Analytics

  • Frost Radar™: Benchmarking Future Growth Potential
  • Frost Radar™: Benchmarking Future Growth Potential
  • Legal Disclaimer